Trial Profile
Proof of Concept Study Concerning Efficacy of P03277 MR Imaging in HCC Diagnosis, Phase IIa Clinical Study
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 07 Oct 2021
Price :
$35
*
At a glance
- Drugs Gadopiclenol (Primary)
- Indications Liver cirrhosis; Liver disorders
- Focus Diagnostic use; Proof of concept
- Sponsors Guerbet
- 04 May 2019 Status changed from recruiting to completed.
- 16 Oct 2018 Planned End Date changed from 1 Sep 2018 to 1 Mar 2019.
- 16 Oct 2018 Planned primary completion date changed from 1 Sep 2018 to 1 Feb 2019.